Roxadustat is a prolyl hydroxylase inhibitor that activates both HIF-1α and HIF-2α, then we studied the effect of HIF-α activation on RXD-induced ferroptosis in GBM cells. The gene discussed is EPAS1; the disease is glioblastoma.